Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc..

Application Number	Patent Number	External Links
-	US7375111	Espacenet Google Patents
-	US7462626	Espacenet Google Patents
-	US8916195	Espacenet Google Patents
-	US9125868	Espacenet Google Patents

COMPLAINT filed against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Actavis, Inc., Andrx Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1733217.) - filed by Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals America, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Civil Cover Sheet)(sar) (Entered: 06/03/2015)

2015-06-03

1

Download

COMPLAINT filed against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Actavis, Inc., Andrx Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1733217.) - filed by Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals America, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Civil Cover Sheet)(sar) (Entered: 06/03/2015)

2015-06-03

2

View

COMPLAINT filed against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Actavis, Inc., Andrx Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1733217.) - filed by Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals America, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Civil Cover Sheet)(sar) (Entered: 06/03/2015)

2015-06-03

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 06/03/2015)

2015-06-03

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 21, 2015. Date of Expiration of Patent: (SEE ATTACHED).Thirty Month Stay Deadline: 10/21/2017. (sar) (Main Document 3 replaced on 6/3/2015) (rwc). (Entered: 06/03/2015)

2015-06-03

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,375,111 B2; 7,462,626 B2; 8,088,786 B2; 8,318,788 B2; 8,722,085 B2;. (sar) (Entered: 06/03/2015)

2015-06-03

1

View

Summons Issued

2015-06-03

1

No Actions

- CORRECTING ENTRY

2015-06-03

1

No Actions

CORRECTING ENTRY: Replaced DI# 3 with correct pdf document. (rwc)

2015-06-03

1

No Actions

Summons Issued with Magistrate Consent Notice attached as to Actavis Laboratories FL, Inc. on 6/3/2015; Actavis Pharma, Inc. on 6/3/2015; Actavis, Inc. on 6/3/2015; Andrx Corporation on 6/3/2015. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar)

2015-06-03

1

No Actions

Return of Service Executed by Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals America, Inc.. Actavis Pharma, Inc. served on 6/4/2015, answer due 6/25/2015. (Kraftschik, Stephen) (Entered: 06/04/2015)

2015-06-04

1

View

Return of Service Executed by Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals America, Inc.. Andrx Corporation served on 6/4/2015, answer due 6/25/2015. (Kraftschik, Stephen) (Entered: 06/04/2015)

2015-06-04

1

View

MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Chad J. Peterman, Irena Royzman, Andrew D. Cohen, and Zhiqiang Liu - filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Kraftschik, Stephen) (Entered: 06/04/2015)

2015-06-04

1

View

DECLARATION Of Mailing, by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibits A-D)(Kraftschik, Stephen) Modified on 6/11/2015 (nms). (Entered: 06/05/2015)

2015-06-05

1

View

Case Assigned/Reassigned

2015-06-10

1

No Actions

Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)

2015-06-10

1

No Actions

Add Attorneys - PHV only

2015-06-11

1

No Actions

SO ORDERED

2015-06-11

1

No Actions

Pro Hac Vice Attorney Willam F Cavanaugh, Jr for Takeda Pharmaceutical Company Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2015-06-11

1

No Actions

SO ORDERED, re 7 MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Chad J. Peterman, Irena Royzman, Andrew D. Cohen, and Zhiqiang Liu filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 6/11/2015. (nms)

2015-06-11

1

No Actions

Add Attorneys - PHV only

2015-06-12

1

No Actions

Pro Hac Vice Attorney Zhiqiang Liu for Takeda Pharmaceutical Company Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)

2015-06-12

1

No Actions

Add Attorneys - PHV only

2015-06-17

1

No Actions

Pro Hac Vice Attorney Irena Royzman,Andrew D. Cohen,Chad J. Peterman for Takeda Pharmaceutical Company Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2015-06-17

1

No Actions

STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to July 27, 2015 - filed by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Actavis, Inc., Andrx Corporation. (Sharp, Melanie) (Entered: 06/23/2015)

2015-06-23

1

View

SO ORDERED

2015-06-23

1

No Actions

SO ORDERED, re 9 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to July 27, 2015 filed by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Actavis, Inc., Andrx Corporation. Signed by Judge Richard G. Andrews on 6/23/2015. (ksr, )

2015-06-23

1

No Actions

STIPULATION of Dismissal, by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Actavis, Inc., Andrx Corporation. (Squire, Monte) Modified on 7/27/2015 (nms). (Entered: 07/24/2015)

2015-07-24

1

View

ANSWER to 1 Complaint, COUNTERCLAIM against Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc. by Actavis Laboratories FL, Inc..(Squire, Monte) Modified on 7/27/2015 (nms). (Entered: 07/27/2015)

2015-07-27

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Actavis Inc. for Actavis Laboratories FL, Inc., Actavis Laboratories FL, Inc. filed by Actavis Laboratories FL, Inc.. (Squire, Monte) (Entered: 07/27/2015)

2015-07-27

1

View

MOTION for Pro Hac Vice Appearance of Attorney Michael W. Johnson and Dan Constantinescu - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 M. Johnson Certification, # 2 D. Constantinescu Certification)(Squire, Monte) (Entered: 07/27/2015)

2015-07-27

1

View

SO ORDERED Granting 10 Stipulation of Dismissal without prejudice (Andrx Corporation, Actavis Pharma, Inc. and Actavis, Inc. terminated). Signed by Judge Richard G. Andrews on 7/28/2015. (nms) (Entered: 07/28/2015)

2015-07-28

1

View

SO ORDERED

2015-07-28

1

No Actions

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Michael W. Johnson and Dan Constantinescu filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 7/28/2015. (nms)

2015-07-28

1

No Actions

Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 9/18/2015, at 3:00 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 8/7/2015. (nms) (Entered: 08/07/2015)

2015-08-07

1

View

ANSWER to 11 Answer to Complaint, and Counterclaims, by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) Modified on 8/21/2015 (nms). (Entered: 08/20/2015)

2015-08-20

1

View

Letter to The Honorable Richard G. Andrews from Stephen J. Kraftschik enclosing proposed Scheduling Order and Table of Proposed Dates. (Attachments: # 1 Exhibits A-B)(Kraftschik, Stephen) Modified on 9/16/2015 (nms). (Entered: 09/16/2015)

2015-09-16

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/31/2016. Amended Pleadings due by 3/31/2016. Discovery due by 9/15/2016. Joint Claim Construction Brief due by 4/28/2016. A Markman Hearing is set for 5/24/2016, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 5/12/2017, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 3 day Bench Trial is set for 6/5/2017, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/18/2015. (nms) (Entered: 09/18/2015)

2015-09-18

1

View

Scheduling Conference

2015-09-18

1

No Actions

Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 9/18/2015. (Court Reporter Valerie Gunning.) (ksr, )

2015-09-18

1

No Actions

Case Referred to Mediation - Magistrate Judge only

2015-09-21

1

No Actions

CASE REFERRED to Judge Thynge for Mediation. (cak)

2015-09-21

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendant's Accused Products and Plaintiffs' Asserted Patents filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/24/2015)

2015-09-24

1

View

NOTICE OF SERVICE of (1) Takeda's Rule 26 Initial Disclosures; and (2) Orexigen's Rule 26 Initial Disclosures filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/30/2015)

2015-09-30

1

View

NOTICE OF SERVICE of Defendant Actavis's Rule 26(a) Initial Disclosures filed by Actavis Laboratories FL, Inc..(Squire, Monte) (Entered: 09/30/2015)

2015-09-30

1

View

MOTION for Pro Hac Vice Appearance of Attorney Thomas J. Meloro - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 Certification by Counsel)(Squire, Monte) (Entered: 09/30/2015)

2015-09-30

1

View

SO ORDERED

2015-09-30

1

No Actions

SO ORDERED, re 22 MOTION for Pro Hac Vice Appearance of Attorney Thomas J. Meloro, filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 9/30/2015. (nms)

2015-09-30

1

No Actions

STIPULATION TO EXTEND TIME to submit a proposed protective order and to submit a proposed order governing Discovery of Electronically Stored Information to October 27, 2015 - filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Kraftschik, Stephen) Modified on 10/20/2015 (nms). (Entered: 10/20/2015)

2015-10-20

1

View

SO ORDERED

2015-10-21

1

No Actions

SO ORDERED, re 23 STIPULATION TO EXTEND TIME to submit a proposed protective order and to submit a proposed order governing Discovery of Electronically Stored Information to October 27, 2015, filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 10/21/2015. (nms)

2015-10-21

1

No Actions

PROPOSED Protective Order, by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Kraftschik, Stephen) Modified on 10/28/2015 (nms). (Entered: 10/27/2015)

2015-10-27

1

View

STIPULATION Regarding Electronic Discovery by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Kraftschik, Stephen) (Entered: 10/27/2015)

2015-10-27

1

View

Add Attorneys - PHV only

2015-10-27

1

No Actions

Pro Hac Vice Attorney Dan Constantinescu, Thomas J. Meloro for Actavis Laboratories FL, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)

2015-10-27

1

No Actions

SO ORDERED re 24 Proposed Protective Order, filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 10/28/2015. (nms) (Entered: 10/28/2015)

2015-10-28

1

View

SO ORDERED re 25 Stipulation Regarding Electronic Discovery, filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 10/28/2015. (nms) (Entered: 10/28/2015)

2015-10-28

1

View

NOTICE OF SERVICE of Takeda's Preliminary Infringement Contentions filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 11/04/2015)

2015-11-04

1

View

NOTICE OF SUBSTITUTION OF COUNSEL re Actavis Laboratories FL, Inc.: Entry of appearance of attorney Robert M. Vrana. Attorney Monte T. Squire terminated. (Vrana, Robert) (Entered: 11/13/2015)

2015-11-13

1

View

ORDER Setting Teleconference: A teleconference has been scheduled for 11/23/15 at 1:30 PM EASTERN TIME with Judge Thynge to discuss ADR. Plaintiffs' counsel shall initiate the teleconference call. Signed by Judge Mary Pat Thynge on 11/19/15. (cak) (Entered: 11/19/2015)

2015-11-19

1

View

ORAL ORDER: As a result of the teleconference of 11/23/15, counsel shall provide on or before 5/4/16, by email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, an update regarding any settlement efforts between the parties, their clients' positions on mediation, the timing when mediation is preferred and any other relevant information that would effect settlement. The email update may be jointly or separately submitted. Ordered by Judge Mary Pat Thynge on 11/23/15. (cak) (Entered: 11/23/2015)

2015-11-23

1

View

Oral Order

2015-11-23

1

No Actions

NOTICE OF SERVICE of Defendant Actavis Laboratories FL, Inc.s Initial Invalidity Contentions for U.S. Patent Nos. 7,375,111, 7,462,626, and 8,916,195 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 12/23/2015)

2015-12-23

1

View

NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendant; and (2) Plaintiffs' First Set of Requests for the Production of Documents and Things to Defendant filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 01/05/2016)

2016-01-05

1

View

NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms for Construction and Proposed Constructions filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 01/07/2016)

2016-01-07

1

View

NOTICE OF SERVICE of Defendant's Identification of Proposed Terms for Claim Construction filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 01/11/2016)

2016-01-11

1

View

NOTICE OF SERVICE of Plaintiffs' Claim Construction Counterproposals filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 01/14/2016)

2016-01-14

1

View

NOTICE OF SERVICE of Takeda's Preliminary Infringement Contentions for the '868 Patent filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 01/19/2016)

2016-01-19

1

View

STIPULATION TO EXTEND TIME to File Joint Claim Construction Chart to February 1, 2016 - filed by Actavis Laboratories FL, Inc.. (Vrana, Robert) Modified on 1/26/2016 (nms). (Entered: 01/26/2016)

2016-01-26

1

View

SO ORDERED

2016-01-27

1

No Actions

SO ORDERED, re 38 STIPULATION TO EXTEND TIME to File Joint Claim Construction Chart to February 1, 2016, filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 1/26/2016. (nms)

2016-01-27

1

No Actions

Joint Claim Construction Chart,by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B Part 1, # 3 Exhibit B Part 2, # 4 Exhibit C, # 5 Exhibit D Part 1, # 6 Exhibit D Part 2, # 7 Exhibit D (Part 3))(Kraftschik, Stephen) Modified on 2/2/2016 (nms). (Entered: 02/01/2016)

2016-02-01

1

View

NOTICE OF SERVICE of Actavis Laboratories FL, Inc.'s Responses and Objections to Plaintiffs' First Set of Interrogatories to Defendant (Nos. 1-6), Actavis Laboratories FL, Inc.'s Responses and Objections to Plaintiffs' First Set of Requests to Defendant for the Production of Documents and Things (Nos. 1-25) filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 02/04/2016)

2016-02-04

1

View

NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 02/26/2016)

2016-02-26

1

View

NOTICE OF SERVICE of Defendant's First Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-63) and Defendant's First Set of Common Interrogatories to Plaintiffs (Nos. 1-12) filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 03/18/2016)

2016-03-18

1

View

NOTICE OF SERVICE of Actavis Laboratories FL, Inc.s Answering Claim Construction Brief filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 03/25/2016)

2016-03-25

1

View

NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Graham, Mary) (Entered: 04/07/2016)

2016-04-07

1

View

STIPULATION and Proposed Order to file the First Amended Complaint, by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibits A-D part 1, # 3 Exhibits A-D, # 4 Exhibit 2)(Kraftschik, Stephen) Modified on 4/15/2016 (nms). (Entered: 04/14/2016)

2016-04-14

1

View

SO ORDERED, Granting 45 Stipulation and Order for leave to amend the complaint, filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 4/15/2016. (nms) (Entered: 04/15/2016)

2016-04-15

1

View

FIRST AMENDED COMPLAINT For Patent Infringement against Actavis Laboratories FL, Inc.- filed by Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals America, Inc.. (Attachments: # 1 Exhibits A-D part 1, # 2 Exhibits A-D part 2)(nms) (Entered: 04/15/2016)

2016-04-15

1

View

NOTICE OF SERVICE of Actavis Laboratories FL, Inc.'s Sur-Reply Claim Construction Brief re 43 Notice of Service filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 04/19/2016)

2016-04-19

1

View

Joint Claim Construction Brief, filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibits 1-9, # 2 Exhibits 10-13)(Graham, Mary) Modified on 4/29/2016 (nms). (Entered: 04/28/2016)

2016-04-28

1

View

ANSWER to 47 Amended Complaint, COUNTERCLAIM against Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc., by Actavis Laboratories FL, Inc..(Vrana, Robert) Modified on 5/3/2016 (nms). (Entered: 05/02/2016)

2016-05-02

1

View

ORAL ORDER: Counsel shall provide on or before 9/28/16, by email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, an update regarding any settlement efforts between the parties, their clients' positions on mediation, the timing when mediation is preferred and any other relevant information that would effect settlement. The email update may be jointly or separately submitted. Ordered by Judge Mary Pat Thynge on 5/4/16. (cak) (Entered: 05/04/2016)

2016-05-04

1

View

Oral Order

2016-05-04

1

No Actions

STIPULATION TO EXTEND TIME to substantially complete document production to June 30, 2016 - filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Kraftschik, Stephen) Modified on 5/5/2016 (nms). (Entered: 05/05/2016)

2016-05-05

1

View

SO ORDERED, re 52 STIPULATION TO EXTEND TIME to substantially complete document production to June 30, 2016, filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 5/5/2016. (nms)

2016-05-05

1

No Actions

NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendant's First Set of Requests for the Production of Documents and Things (Nos. 1-63); and (2) Plaintiffs' Response to Defendant's First Set of Common Interrogatories to Plaintiffs (Nos. 1-12) filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 05/06/2016)

2016-05-06

1

View

SO ORDERED

2016-05-06

1

No Actions

ORAL ORDER: Due to a scheduling conflict the Markman Hearing set for 5/24/2016, at 9:00 AM will now be held in Courtroom 2A before Judge Richard G. Andrews. Ordered by Judge Richard G. Andrews on 5/10/2016. (nms) (Entered: 05/10/2016)

2016-05-10

1

View

~Util - Set Hearings AND Oral Order

2016-05-10

1

No Actions

Markman Hearing

2016-05-24

1

No Actions

Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 5/24/2016. Appearances: Sharp, Vrana, Meloro, Johnson, Constantinescu, Cavanaugh, Peterman, Kraftschik. (Court Reporter Leonard Dibbs.) (ksr, )

2016-05-24

1

No Actions

Official Transcript of Markman Hearing held on 05-24-16 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/16/2016. Redacted Transcript Deadline set for 6/27/2016. Release of Transcript Restriction set for 8/24/2016. (lad) (Entered: 05/26/2016)

2016-05-26

1

View

ANSWER to 50 Answer to Amended Complaint,, Counterclaim, by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 05/26/2016)

2016-05-26

1

View

NOTICE OF SERVICE of Defendant's Second Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 64-79) and Defendant's Second Set of Interrogatories to Plaintiffs (Nos. 13-16) filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 05/27/2016)

2016-05-27

1

View

Letter to The Honorable Richard G. Andrews from Stephen J. Kraftschik regarding claim limitation. (Kraftschik, Stephen) (Entered: 05/31/2016)

2016-05-31

1

View

Letter to The Honorable Richard G. Andrews from Robert M. Vrana, Esq. regarding Response to Request During May 24, 2016 Markman Hearing. (Vrana, Robert) (Entered: 05/31/2016)

2016-05-31

1

View

MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent Nos. 7,462,626 and 8,916,195. Within five day the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 6/6/2016. (nms) (Entered: 06/06/2016)

2016-06-06

1

Download

PROPOSED ORDER regarding Claim Construction, by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Attachments: # 1 Letter)(Graham, Mary) Modified on 6/10/2016 (nms). (Entered: 06/10/2016)

2016-06-10

1

View

CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 6/10/2016. (nms) (Entered: 06/10/2016)

2016-06-10

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Response to Defendant's Second Set of Interrogatories to Plaintiffs (Nos. 13-16); and (2) Plaintiffs' Responses to Defendant's Second Set of Requests for the Production of Documents and Things (Nos. 64-79) filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Raucci, Anthony) (Entered: 06/29/2016)

2016-06-29

1

View

NOTICE OF SERVICE of Defendant Actavis Laboratories FL, Inc.'s Initial Invalidity Contentions for U.S. Patent No. 9,125,868 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 07/25/2016)

2016-07-25

1

View

NOTICE of Change of Firm Affiliation and Withdrawal of Appearance as to Takeda of Chad J. Peterman by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc. (Kraftschik, Stephen) (Entered: 08/09/2016)

2016-08-09

1

View

NOTICE requesting Clerk to remove William F. Cavanaugh, Irena Royzman, Andrew D. Cohen and Zhiqiang Liu as co-counsel. Reason for request: Withdrawal of Appearance as to Orexigen. (Kraftschik, Stephen) (Entered: 08/09/2016)

2016-08-09

1

View

NOTICE to Take Deposition of Plaintiffs Takeda Pharmaceuticals Company Limited, Takeda Pharmaceuticals International GMBH Takeda Pharmaceuticals USA, Inc., and Takeda Pharmaceuticals America, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on August 31, 2016 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 08/12/2016)

2016-08-12

1

View

NOTICE to Take Deposition of Plaintiff Orexigen Therapeutics, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on September 2, 2016 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 08/12/2016)

2016-08-12

1

View

NOTICE to Take Deposition of Alison Handley on September 16, 2016 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE to Take Deposition of Gray Scholhamer Hulick on September 21, 2016 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE to Take Deposition of Katie Andino on September 14, 2016 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE of Subpoenas Directed to Michael Cowley by Actavis Laboratories FL, Inc. (Attachments: # 1 Subpoena to Testify at Deposition, # 2 Subpoena to Produce Documents)(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE of Subpoenas Directed to Thea Elise Dunzo by Actavis Laboratories FL, Inc. (Attachments: # 1 Subpoena to Testify at Deposition, # 2 Subpoena to Produce Documents)(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE of Subpoenas Directed to Anthony McKinney by Actavis Laboratories FL, Inc. (Attachments: # 1 Subpoena to Testify at Deposition, # 2 Subpoena to Produce Documents)(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE of Subpoenas Directed to Richard Soltero by Actavis Laboratories FL, Inc. (Attachments: # 1 Subpoena to Testify at Deposition, # 2 Subpoena to Produce Documents)(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE of Subpoenas Directed to Eckard Weber by Actavis Laboratories FL, Inc. (Attachments: # 1 Subpoena to Testify at Deposition, # 2 Subpoena to Produce Documents)(Vrana, Robert) (Entered: 08/26/2016)

2016-08-26

1

View

NOTICE of Appearance of Chad J. Peterman as Co-Counsel for Plaintiffs by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc. (Kraftschik, Stephen) (Entered: 08/26/2016)

2016-08-26

1

View

STIPULATION and Proposed Order to amend Scheduling Order, by Actavis Laboratories FL, Inc.. (Vrana, Robert) Modified on 9/6/2016 (nms). (Entered: 09/02/2016)

2016-09-02

1

View

SO ORDERED

2016-09-06

1

No Actions

SO ORDERED, re 78 Stipulation and Order amending scheduling deadlines, filed by Actavis Laboratories FL, Inc. (see Stipulation for further details). Signed by Judge Richard G. Andrews on 9/6/2016. (nms)

2016-09-06

1

No Actions

NOTICE OF SERVICE of (i) Objections by Anthony McKinney to Non-Party Subpoena; (ii) Objections by Michael Cowley to Non-Party Subpoena; and (iii) Objections by Eckard Weber to Non-Party Subpoena filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/08/2016)

2016-09-08

1

View

NOTICE to Take Deposition of Actavis Laboratories FL, Inc. on October 3, 2016 filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/08/2016)

2016-09-08

1

View

NOTICE OF SERVICE of (1) Plaintiff Takeda Pharmaceutical Company, Ltd, Takeda Pharmaceuticals International GMBH, Takeda Pharmaceuticals USA, Inc. and Takeda Pharmaceuticals America, Inc.'s Response to Defendant Actavis's Notice of 30(b)(6) Deposition; (2) Plaintiff Orexigen Therapeutics, Inc.'s Response to Defendant Actavis' Notice of 30(b)(6) Deposition filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/08/2016)

2016-09-08

1

View

MOTION for Pro Hac Vice Appearance of Attorney Simon F. Kung, Michael Werno, and Bruce M. Wexler of Paul Hastings LLP - filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Kraftschik, Stephen) (Entered: 09/09/2016)

2016-09-09

1

View

SO ORDERED

2016-09-09

1

No Actions

SO ORDERED, re 82 MOTION for Pro Hac Vice Appearance of Attorney Simon F. Kung, Michael Werno, and Bruce M. Wexler of Paul Hastings LLP filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International GmbH, Orexigen Therapeutics, Inc., Takeda Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 9/9/2016. (nms)

2016-09-09

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendant filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/14/2016)

2016-09-14

1

View

NOTICE OF SERVICE of (1) Objections by Thea Elise Dunzo to Non-Party Subpoena; and (2) Objections by Richard Soltero to Non-Party Subpoena filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/22/2016)

2016-09-22

1

View

NOTICE of Subpoenas to Preston Klassen by Actavis Laboratories FL, Inc. (Attachments: # 1 Subpoenas)(Vrana, Robert) (Entered: 09/22/2016)

2016-09-22

1

View

ORAL ORDER: A teleconference has been scheduled for 10/24/16 at 9:30 AM Eastern Time with Judge Thynge to discuss the status of the case. Counsel for plaintiffs shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 9/28/16. (cak) (Entered: 09/28/2016)

2016-09-28

1

View

Oral Order

2016-09-28

1

No Actions

NOTICE to Take Deposition of Craig Jones on October 13, 2016 filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/30/2016)

2016-09-30

1

View

NOTICE to Take Deposition of Janet Vaughn on October 19, 2016 filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/30/2016)

2016-09-30

1

View

NOTICE to Take Deposition of Suparna Mukherjee on October 21, 2016 filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/30/2016)

2016-09-30

1

View

NOTICE to Take Deposition of Arun Kaliaperumal on October 25, 2016 filed by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc..(Kraftschik, Stephen) (Entered: 09/30/2016)

2016-09-30

1

View

STIPULATION regarding withdrawal of Takeda plaintiffs by Orexigen Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International GmbH, Takeda Pharmaceuticals USA, Inc.. (Kraftschik, Stephen) (Entered: 10/05/2016)

2016-10-05

1

View

SO ORDERED Granting 91 Stipulation and Order (see Stipulation for further details). Signed by Judge Richard G. Andrews on 10/5/2016. (nms) (Entered: 10/05/2016)

2016-10-05

1

View

MOTION for Pro Hac Vice Appearance of Attorney Erin E. McLeod - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 Certification by Counsel)(Vrana, Robert) (Entered: 10/10/2016)

2016-10-10

1

View

NOTICE OF SERVICE of Defendant Actavis Laboratories FL, Inc.'s Objections and Responses to Plaintiff's Notice of 30(b)(6) Deposition filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 10/10/2016)

2016-10-10

1

View

SO ORDERED

2016-10-11

1

No Actions

SO ORDERED, re 93 MOTION for Pro Hac Vice Appearance of Attorney Erin E. McLeod filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 10/11/2016. (nms)

2016-10-11

1

No Actions

STIPULATION extending scheduling order dates, by Actavis Laboratories FL, Inc.. (Vrana, Robert) Modified on 10/14/2016 (nms). (Entered: 10/13/2016)

2016-10-13

1

View

SO ORDERED

2016-10-14

1

No Actions

SO ORDERED, re 95 Stipulation and Order extending Scheduling Order deadlines, filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 10/14/2016. (nms)

2016-10-14

1

No Actions

NOTICE of Subpoena Directed to Ned Israelson by Actavis Laboratories FL, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Vrana, Robert) Modified on 10/21/2016 (nms). (Entered: 10/20/2016)

2016-10-20

1

View

NOTICE OF SERVICE of Actavis Laboratories FL, Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories (No. 7) filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 10/21/2016)

2016-10-21

1

View

NOTICE OF SERVICE of Actavis Laboratories FL, Inc.'s Supplemental Responses to Plaintiff's First Set of Interrogatories (No. 6) and Second Set of Interrogatories (No. 7) and Defendant Actavis Laboratories FL, Inc.'s Supplemental Invalidity Contentions for U.S. Patent Nos. 7,375,111, 7,462,626, 8,916,195, and 9,125,868 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 10/28/2016)

2016-10-28

1

View

NOTICE OF SERVICE of Expert Report of Dr. Rexford S. Ahima, M.D., Ph.D., and Expert Report of Michael Mayersohn, Ph.D. filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 12/07/2016)

2016-12-07

1

View

STIPULATION and Proposed Order to Extend Scheduling Order deadlines, by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 1/17/2017 (nms). (Entered: 01/13/2017)

2017-01-13

1

View

SO ORDERED

2017-01-17

1

No Actions

SO ORDERED, re 100 Stipulation to extend scheduling order deadlines. Signed by Judge Richard G. Andrews on 1/17/2017. (nms)

2017-01-17

1

No Actions

ORAL ORDER: IT IS ORDERED that counsel shall update Judge Thynge as to the status of the case and the parties' positions regarding mediation on or before February 3, 2017. The updates are limited to no more than three (3) pages. Ordered by Judge Mary Pat Thynge on 1/20/17. (cak) (Entered: 01/20/2017)

2017-01-20

1

View

Add Attorneys - PHV only

2017-01-20

1

No Actions

Oral Order

2017-01-20

1

No Actions

Pro Hac Vice Attorney Bruce M. Wexler for Orexigen Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)

2017-01-20

1

No Actions

NOTICE OF SERVICE of Rebuttal Expert Report of Dr. Rexford S. Ahima, M.D., Ph.D. filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 01/25/2017)

2017-01-25

1

View

MOTION for Pro Hac Vice Appearance of Attorney Eugene L. Chang - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 Certification by Counsel)(Vrana, Robert) (Entered: 02/10/2017)

2017-02-10

1

View

SO ORDERED

2017-02-13

1

No Actions

SO ORDERED, re 103 MOTION for Pro Hac Vice Appearance of Attorney Eugene L. Chang, filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 2/13/2017. (nms)

2017-02-13

1

No Actions

NOTICE OF SERVICE of Reply Expert Report of Dr. Rexford S. Ahima, M.D., Ph.D., the Reply Expert Report of Michael Mayersohn, Ph.D. filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 02/22/2017)

2017-02-22

1

View

NOTICE to Take Deposition of Donald J. Treacy, Ph.D. on March 9, 2017 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 02/27/2017)

2017-02-27

1

View

Notice to Take Deposition

2017-02-27

1

View

NOTICE to Take Deposition of Randy J. Seeley, Ph.D. on March 24, 2017 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 02/27/2017)

2017-02-27

1

View

NOTICE to Take Deposition of Michael Mayersohn, Ph.D. on March 3, 2017 filed by Orexigen Therapeutics, Inc..(Kraftschik, Stephen) (Entered: 02/27/2017)

2017-02-27

1

View

NOTICE to Take Deposition of John M. Amatruda, M.D. on March 7, 2017 filed by Actavis Laboratories FL, Inc..(Vrana, Robert) (Entered: 02/28/2017)

2017-02-28

1

View

- CORRECTING ENTRY

2017-02-28

1

No Actions

CORRECTING ENTRY: The Notice to Take Deposition filed at D.I. 106 has been removed from the docket. The docket text indicated the notice was for John M. Amatruda, but the filing was tailored for a Mr. Seeley. Counsel shall refile the correct notice. (nms)

2017-02-28

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Jonathan D. Ball, Ph.D., Richard C. Pettus and Scott J. Bornstein - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 Certifications by Counsel)(Vrana, Robert) (Entered: 03/07/2017)

2017-03-07

1

View

SO ORDERED

2017-03-07

1

No Actions

SO ORDERED, re 110 MOTION for Pro Hac Vice Appearance of Attorney Jonathan D. Ball, Ph.D., Richard C. Pettus and Scott J. Bornstein, filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 3/7/2017. (nms)

2017-03-07

1

No Actions

NOTICE to Take Deposition of Rexford S. Ahima on March 29, 2017 filed by Orexigen Therapeutics, Inc..(Kraftschik, Stephen) (Entered: 03/21/2017)

2017-03-21

1

View

MOTION for Pro Hac Vice Appearance of Attorney Justin A. MacLean - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 Certification by Counsel)(Vrana, Robert) (Entered: 03/27/2017)

2017-03-27

1

View

Add Attorneys - PHV only

2017-03-28

1

No Actions

SO ORDERED

2017-03-28

1

No Actions

SO ORDERED, re 112 MOTION for Pro Hac Vice Appearance of Attorney Justin A. MacLean, filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 3/28/2017. (nms)

2017-03-28

1

No Actions

Pro Hac Vice Attorney Scott J. Bornstein,Jonathan Ball,Richard C. Pettus for Actavis Laboratories FL, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)

2017-03-28

1

No Actions

Add Attorneys - PHV only

2017-03-29

1

No Actions

Pro Hac Vice Attorney Justin A. MacLean for Actavis Laboratories FL, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)

2017-03-29

1

No Actions

NOTICE of Withdrawal of Pro Hac Vice Counsel, Willkie Farr & Gallagher, LLP by Actavis Laboratories FL, Inc. (Vrana, Robert) (Entered: 04/05/2017)

2017-04-05

1

View

NOTICE OF SERVICE of Defendant Actavis' Supplemental Rule 26(A) Initial Disclosures filed by Actavis Laboratories FL, Inc..(Sharp, Melanie) (Entered: 04/25/2017)

2017-04-25

1

View

ORDER: Due to a scheduling conflict the Pretrial Conference set for 5/12/2017, is CONTINUED, and is now rescheduled for 5/15/2017, at 3:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 5/5/2017. (nms) (Entered: 05/05/2017)

2017-05-05

1

View

NOTICE of Pursuant to 35 U.S.C § 282 by Actavis Laboratories FL, Inc. (Higgins, James) (Entered: 05/05/2017)

2017-05-05

1

View

[SEALED] Proposed Pretrial Order, Volume 1 of 3, by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-19))(Kraftschik, Stephen) Modified on 5/8/2017 (nms). (Entered: 05/05/2017)

2017-05-05

1

View

[SEALED] Proposed Pretrial Order, Volume 2 of 3, by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 5/8/2017 (nms). (Main Document 118 replaced on 5/12/2017) (nms). (Entered: 05/05/2017)

2017-05-05

1

View

[SEALED] Proposed Pretrial Order, Volume 3 of 3, by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 5/8/2017 (nms). (Main Document 119 replaced on 5/10/2017) (nms). (Main Document 119 replaced on 5/12/2017) (nms). (Entered: 05/05/2017)

2017-05-05

1

View

1 - Terminate Hearings AND ~Util - Set Hearings AND Order

2017-05-05

1

No Actions

Add Attorneys - PHV only

2017-05-09

1

No Actions

Pro Hac Vice Attorney Simon F. Kung for Orexigen Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)

2017-05-09

1

No Actions

CORRECTING ENTRY: The pdf for D.I. 119 has been replaced per counsel's request. Exhibit 24 was inadvertently omitted in the initial filing, and has now been added. (nms)

2017-05-10

1

No Actions

- CORRECTING ENTRY

2017-05-10

1

No Actions

CORRECTING ENTRY: The appendix and exhibits filed at D.I. 120 have been removed from the docket. Trial exhibits do not get filed on the docket. (nms)

2017-05-11

1

No Actions

- CORRECTING ENTRY

2017-05-11

1

No Actions

CORRECTING ENTRY: The pdfs for D.I. 118 and D.I. 119 have been replaced. The index found in D.I. 118 has been updated, and exhibits have been added to D.I. 119 . (nms)

2017-05-12

1

No Actions

- CORRECTING ENTRY

2017-05-12

1

No Actions

Letter to The Honorable Richard G. Andrews from James L. Higgins, Esq. regarding Developments involving pending Motions in Limine, in advance of Pretrial Conference. (Higgins, James) (Entered: 05/15/2017)

2017-05-15

1

View

Letter to The Honorable Richard G. Andrews from Mary B. Graham regarding Orexigen's response to Actavis's letter - re 120 Letter. (Graham, Mary) (Entered: 05/15/2017)

2017-05-15

1

View

Minute Entry for proceedings held before Judge Richard G. Andrews - Final Pretrial Conference held on 5/15/2017. Appearances; M. Graham, B. Wexler, C. Peterman for Plaintiff; J. Higgins, S. Bernstein, R. Pettus, J. Bell, J. Maclean for Defendant. (Court Reporter Valerie Gunning.) (ksr, )

2017-05-15

1

No Actions

ORDER After Pretrial Conference (see Order for further details). Signed by Judge Richard G. Andrews on 5/16/2017. (nms) (Entered: 05/16/2017)

2017-05-16

1

Download

[SEALED] Letter to The Honorable Richard G. Andrews from James L. Higgins, Esq. regarding Actavis' submission of specific combination of references that it seeks to rely upon at trial. (Higgins, James) (Entered: 05/16/2017)

2017-05-16

1

View

Pretrial Conference - Final

2017-05-16

1

No Actions

[SEALED] Letter to The Honorable Richard G. Andrews from James L. Higgins, Esq. regarding Objections to New Paragraphs of Contested Facts Served by Plaintiffs. (Higgins, James) (Entered: 05/17/2017)

2017-05-17

1

View

[SEALED] Letter to The Honorable Richard G. Andrews from Orexigen regarding Responding to Defendant's Letter of May 16, 2017 Regarding Obviousness Combination. (Attachments: # 1 Exhibits A-B)(Kraftschik, Stephen) Modified on 5/19/2017 (nms). (Entered: 05/18/2017)

2017-05-18

1

View

Letter to The Honorable Richard G. Andrews from Mary B. Graham regarding Orexigen's response to Actavis's letter regarding Orexigen's infringement proofs - re 124 Letter. (Attachments: # 1 Exhibits A-D)(Graham, Mary) (Entered: 05/18/2017)

2017-05-18

1

View

Letter to The Honorable Richard G. Andrews from James L. Higgins, Esq. regarding Submission of CV's for Witnesses Actavis Expects to Call Live at Trial. (Attachments: # 1 Exhibit A-B)(Higgins, James) (Main Document 127 replaced on 5/19/2017) (nms). Modified on 5/19/2017 (nms). (Entered: 05/19/2017)

2017-05-19

1

View

Letter to The Honorable Richard G. Andrews from Stephen J. Kraftschik regarding curricula vitae for Planitiff's experts. (Attachments: # 1 Exhibit 1 - 4)(Kraftschik, Stephen) (Entered: 05/19/2017)

2017-05-19

1

View

MEMORANDUM ORDER regarding two disputes that arose at the pretrial conference (D.I. 123, 124, 125, 126 ). Signed by Judge Richard G. Andrews on 5/19/2017. (nms) (Entered: 05/19/2017)

2017-05-19

1

Download

[SEALED] Letter to The Honorable Richard G. Andrews from James L. Higgins, Esq. regarding response to Orexigen's May 18, 2017 Letter. (Higgins, James) Modified on 5/22/2017 (nms). (Entered: 05/19/2017)

2017-05-19

1

View

- CORRECTING ENTRY

2017-05-19

1

No Actions

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI # 117, 118, and 119 . (nms)

2017-05-19

1

No Actions

Deficiency re Redacted Documents

2017-05-19

1

No Actions

CORRECTING ENTRY: The pdf for D.I. 127 has been replaced per counsel's request. The exhibits to the letter have been corrected. (nms)

2017-05-19

1

No Actions

REDACTED VERSION of 117 Proposed Pretrial Order, Volume 1 of 3, by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 5/23/2017 (nms). (Entered: 05/23/2017)

2017-05-23

1

View

REDACTED VERSION of 118 Proposed Pretrial Order, Volume 2 of 3, by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 5/23/2017 (nms). (Entered: 05/23/2017)

2017-05-23

1

View

REDACTED VERSION of 119 Proposed Pretrial Order, Volume 3 of 3, by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 5/23/2017 (nms). (Entered: 05/23/2017)

2017-05-23

1

View

- CORRECTING ENTRY

2017-05-23

1

No Actions

Deficiency re Redacted Documents

2017-05-23

1

No Actions

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI # 117, 118, and 119 . (nms)

2017-05-23

1

No Actions

CORRECTING ENTRY: The redacted document filed at D.I. 133 has been removed per counsel's request. Further redactions were needed. Counsel will refile shortly. (nms)

2017-05-23

1

No Actions

NOTICE of Subpoena on Kishore M. Gadde, MD by Orexigen Therapeutics, Inc. (Kraftschik, Stephen) (Entered: 05/24/2017)

2017-05-24

1

View

REDACTED VERSION of 123 Letter, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 5/25/2017 (nms). (Entered: 05/25/2017)

2017-05-25

1

View

REDACTED VERSION of 124 Letter, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 5/25/2017 (nms). (Entered: 05/25/2017)

2017-05-25

1

View

REDACTED VERSION of 130 Letter, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 5/25/2017 (nms). (Entered: 05/25/2017)

2017-05-25

1

View

Official Transcript of Pretrial Conference held on 05-15-17 before Judge Richard G. Andrews. Court Reporter/Transcriber Valerie J. Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/20/2017. Redacted Transcript Deadline set for 6/30/2017. Release of Transcript Restriction set for 8/28/2017. (lad) (Entered: 05/30/2017)

2017-05-30

1

View

NOTICE OF SERVICE of Supplemental Expert Report of Randy J. Seeley, Ph.D. filed by Orexigen Therapeutics, Inc..(Kraftschik, Stephen) (Entered: 05/30/2017)

2017-05-30

1

View

MEMORANDUM ORDER: The issued raised in Defendant's letter (D.I. 130 ) have been considered, and the Order of May 19, 2017 (D.I. 129 ) will not be altered. Signed by Judge Richard G. Andrews on 5/31/2017. (nms) (Entered: 05/31/2017)

2017-05-31

1

Download

Deficiency re Redacted Documents

2017-05-31

1

No Actions

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 125 . (nms)

2017-05-31

1

No Actions

REDACTED VERSION of 125 Letter, by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibits A-B)(Kraftschik, Stephen) Modified on 6/1/2017 (nms). (Entered: 06/01/2017)

2017-06-01

1

View

[SEALED] Letter to The Honorable Richard G. Andrews from Mary B. Graham regarding evidence from Actavis's Public Use fact witness, Dr. Kishore Gadde. (Attachments: # 1 Exhibits A-D)(Graham, Mary) (Entered: 06/01/2017)

2017-06-01

1

View

[SEALED] Letter to The Honorable Richard G. Andrews from James L. Higgins, Esq., responding to Orexigen's June 1, 2017 Letter. (Attachments: # 1 Exhibits A-L)(Higgins, James) Modified on 6/2/2017 (nms). (Entered: 06/02/2017)

2017-06-02

1

View

[SEALED] Letter to The Honorable Richard G. Andrews from Mary B. Graham regarding Orexigen's reply letter regarding evidence from Actavis's public use fact witness, Dr. Kishore Gadde - re 143 Letter. (Attachments: # 1 Exhibits 1-3)(Graham, Mary) (Entered: 06/04/2017)

2017-06-04

1

View

MOTION for Pro Hac Vice Appearance of Attorney Richard Mills-Robertson and Rachel Wu - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 Certifications by Counsel)(Higgins, James) (Entered: 06/04/2017)

2017-06-04

1

View

STIPULATION and Proposed Order, by Actavis Laboratories FL, Inc.. (Attachments: # 1 Exhibit A)(Higgins, James) Modified on 6/5/2017 (nms). (Entered: 06/04/2017)

2017-06-04

1

View

SO ORDERED, re 145 MOTION for Pro Hac Vice Appearance of Attorney Richard Mills-Robertson and Rachel Wu, filed by Actavis Laboratories FL, Inc.. Signed by Judge Richard G. Andrews on 6/5/2017. (nms)

2017-06-05

1

No Actions

SO ORDERED, re 146 Stipulation and Proposed Order regarding trial exhibits. Signed by Judge Richard G. Andrews on 6/5/2017. (nms)

2017-06-05

1

No Actions

Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, Day 1 held on 6/5/2017. (Court Reporter Leonard Dibbs/Valerie Gunning.) (ksr, )

2017-06-05

1

No Actions

SO ORDERED

2017-06-05

1

No Actions

Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, Day 2 held on 6/6/2017. (Court Reporter Leonard Dibbs/Valerie Gunning.) (ksr, )

2017-06-06

1

No Actions

Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, Day 3 completed on 6/7/2017. (Court Reporter Leonard Dibbs/Valerie Gunning.) (ksr, )

2017-06-07

1

No Actions

REDACTED VERSION of 143 Letter, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 6/12/2017 (nms). (Entered: 06/09/2017)

2017-06-09

1

View

Letter to The Honorable Richard G. Andrews from Mary B. Graham regarding schedule for post-trial submissions. (Attachments: # 1 Exhibits A-C)(Graham, Mary) (Entered: 06/12/2017)

2017-06-12

1

View

Deficiency re Redacted Documents

2017-06-12

1

No Actions

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 142 . (nms)

2017-06-12

1

No Actions

REDACTED VERSION of 142 Letter, by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibits A-D)(Kraftschik, Stephen) Modified on 6/13/2017 (nms). (Entered: 06/13/2017)

2017-06-13

1

View

REDACTED VERSION of 144 Letter, by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-3)(Kraftschik, Stephen) Modified on 6/13/2017 (nms). (Entered: 06/13/2017)

2017-06-13

1

View

ORDER Regarding Post-Trial Submissions. Signed by Judge Richard G. Andrews on 6/13/2017. (nms) (Entered: 06/13/2017)

2017-06-13

1

View

Witness List from Bench Trial held 6/5/2017 thru 6/7/2017. (ksr, ) (Entered: 06/15/2017)

2017-06-15

1

View

[SEALED] Opening Post-Trial Brief Regarding Invalidity of the Patents-In-Suit, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 6/16/2017 (nms). (Entered: 06/15/2017)

2017-06-15

1

View

Proposed Findings of Fact by Orexigen Therapeutics, Inc.. (Graham, Mary) (Entered: 06/15/2017)

2017-06-15

1

View

Bench Trial - Held

2017-06-15

1

No Actions

Bench Trial - Completed

2017-06-15

1

No Actions

Bench Trial - Begun

2017-06-15

1

No Actions

MOTION to Strike Gadde 2003 Fax - filed by Orexigen Therapeutics, Inc.. (Graham, Mary) Modified on 6/23/2017 (nms). (Entered: 06/22/2017)

2017-06-22

1

View

Response to 154 Proposed Findings of Fact and Additional Proposed Findings of Fact Relating to Infringement, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 6/23/2017 (nms). (Entered: 06/22/2017)

2017-06-22

1

View

[SEALED] POST-TRIAL BRIEF Regarding Validity of the Patents-In-Suit, by Orexigen Therapeutics, Inc.. (Graham, Mary) Modified on 6/23/2017 (nms). (Entered: 06/22/2017)

2017-06-22

1

View

REDACTED VERSION of 153 POST-Trial Brief Regarding Invalidity of the Patents-In-Suit, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 6/23/2017 (nms). (Entered: 06/22/2017)

2017-06-22

1

View

ANSWERING BRIEF in Opposition re 155 MOTION to Strike Gadde 2003 Fax filed by Actavis Laboratories FL, Inc..Reply Brief due date per Local Rules is 7/6/2017. (Higgins, James) (Entered: 06/29/2017)

2017-06-29

1

View

[SEALED] POST-TRIAL Reply Brief Regarding Invalidity of the Patents-In-Suit, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 7/5/2017 (nms). (Entered: 06/29/2017)

2017-06-29

1

View

REPLY to 156 Proposed Findings of Fact on Infringement, by Orexigen Therapeutics, Inc.. (Graham, Mary) Modified on 7/5/2017 (nms). (Entered: 06/29/2017)

2017-06-29

1

View

Corrected Post-Trial Opening Brief Regarding Invalidity of the Patents-in-Suit, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 7/5/2017 (nms). (Entered: 07/03/2017)

2017-07-03

1

View

Corrected Proposed Findings of Fact on Infringement, by Orexigen Therapeutics, Inc.. (Graham, Mary) Modified on 7/5/2017 (nms). (Entered: 07/05/2017)

2017-07-05

1

View

[SEALED] Corrected Post-Trial Brief Regarding Validity of the Patents-In-Suit, by Orexigen Therapeutics, Inc.. (Graham, Mary) Modified on 7/5/2017 (nms). (Entered: 07/05/2017)

2017-07-05

1

View

Corrected Responses to Proposed Findings of Fact and Additional Proposed Findings of Fact Relating to Infringement, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 7/6/2017 (nms). (Entered: 07/05/2017)

2017-07-05

1

View

Corrected Reply to Proposed Findings of Fact on Infringement, by Orexigen Therapeutics, Inc.. (Graham, Mary) Modified on 7/6/2017 (nms). (Entered: 07/06/2017)

2017-07-06

1

View

REDACTED VERSION of 160 Reply Post-Trial Brief Regarding Invalidity of the Patents-In-Suit, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 7/6/2017 (nms). (Entered: 07/06/2017)

2017-07-06

1

View

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 157 . (nms)

2017-07-06

1

No Actions

Deficiency re Redacted Documents

2017-07-06

1

No Actions

Letter to The Honorable Richard G. Andrews from Stephen J. Kraftschik regarding enclosing joint Admitted Trial Exhibit List. (Attachments: # 1 List of Admitted Exhibits)(Kraftschik, Stephen) (Entered: 07/07/2017)

2017-07-07

1

View

Letter to The Honorable Richard G. Andrews from Stephen J. Kraftschik regarding enclosing disks containing confidential post-trial briefing - re 151 Order. (Kraftschik, Stephen) (Entered: 07/07/2017)

2017-07-07

1

View

Letter to The Honorable Richard G. Andrews from James L. Higgins, Esq. enclosing electronic hyperlinked versions of Actavis's Post-Trial Briefs and copies of DTX Admitted Exhibits. (Higgins, James) Modified on 7/7/2017 (nms). (Entered: 07/07/2017)

2017-07-07

1

View

REPLY BRIEF re 155 MOTION to Strike Gadde 2003 Fax filed by Orexigen Therapeutics, Inc.. (Graham, Mary) (Entered: 07/07/2017)

2017-07-07

1

View

POST-TRIAL BRIEF Regarding the Issue of Divided Infringement of the '626 Patent, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 7/10/2017 (nms). (Entered: 07/07/2017)

2017-07-07

1

View

POST-TRIAL BRIEF on the Issue of Divided Infringement, by Orexigen Therapeutics, Inc.. (Graham, Mary) Modified on 7/10/2017 (nms). (Entered: 07/07/2017)

2017-07-07

1

View

REDACTED VERSION of 157 POST-Trial Brief re Validity of the Patents-in-Suit, by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 7/11/2017 (nms). (Entered: 07/11/2017)

2017-07-11

1

View

Letter to the Honorable Richard G. Andrews from James L. Higgins, Esq. enclosing Actavis's Electronic Hyperlinked Post-Trial Briefs. (Higgins, James) Modified on 7/11/2017 (nms). (Entered: 07/11/2017)

2017-07-11

1

View

Letter to The Honorable Richard G. Andrews from Stephen J. Kraftschik regarding Replacement Disc containing Hyperlinked Submissions - re 169 Letter. (Kraftschik, Stephen) (Entered: 07/11/2017)

2017-07-11

1

View

SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 157 . (nms)

2017-07-11

1

No Actions

Deficiency re Redacted Documents

2017-07-11

1

No Actions

REDACTED VERSION of 164 POST Trial Brief by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) (Entered: 07/17/2017)

2017-07-17

1

View

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 164 . (nms)

2017-07-17

1

No Actions

Deficiency re Redacted Documents

2017-07-17

1

No Actions

Official Transcript of Bench Trial (Day 1) held on 06-05-17 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/19/2017. Redacted Transcript Deadline set for 9/29/2017. Release of Transcript Restriction set for 11/27/2017. (lad) (Entered: 08/29/2017)

2017-08-29

1

View

Official Transcript of Bench Trial (Day 2) held on 06-06-17 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/19/2017. Redacted Transcript Deadline set for 9/29/2017. Release of Transcript Restriction set for 11/27/2017. (lad) (Entered: 08/29/2017)

2017-08-29

1

View

Official Transcript of Bench Trial (Day 3) held on 06-07-17 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/19/2017. Redacted Transcript Deadline set for 9/29/2017. Release of Transcript Restriction set for 11/27/2017. (lad) (Entered: 08/29/2017)

2017-08-29

1

View

Stipulation and Proposed Order of Dismissal of U.S. Patent No. 9,125,868 and Certain Other Claims, by Actavis Laboratories FL, Inc.. (Higgins, James) Modified on 8/31/2017 (nms). (Entered: 08/30/2017)

2017-08-30

1

View

SO ORDERED Granting 181 Stipulation and Order of Dismissal of U.S. Patent No. 9,125,868 and Certain Other Claims. Signed by Judge Richard G. Andrews on 8/31/2017. (nms) (Entered: 08/31/2017)

2017-08-31

1

Download

Letter to The Honorable Richard G. Andrews from Mary B. Graham regarding upcoming end of 30-month stay. (Graham, Mary) (Entered: 10/13/2017)

2017-10-13

1

Download

TRIAL OPINION. Plaintiff should submit an agreed upon form of final judgment within two weeks. Signed by Judge Richard G. Andrews on 10/13/2017. (nms) (Entered: 10/13/2017)

2017-10-13

1

Download

PROPOSED Final Judgment, by Orexigen Therapeutics, Inc.. (Attachments: # 1 Letter)(Graham, Mary) Modified on 10/26/2017 (nms). (Entered: 10/26/2017)

2017-10-26

1

View

FINAL JUDGMENT (CASE CLOSED). Signed by Judge Richard G. Andrews on 10/26/2017. (nms) (Entered: 10/26/2017)

2017-10-26

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,375,111 B2; 7,462,626 B2; 8,088,786 B2; 8,318,788 B2; 8,722,085 B2; 8,815,889 B2; 8,916,195 B2. (Attachments: # 1 Judgment)(nms) (Entered: 10/26/2017)

2017-10-26

1

View

NOTICE OF APPEAL to the Federal Circuit of 140 Memorandum and Order, 186 Judgment, 62 Order, 129 Memorandum and Order, 184 Opinion . Appeal filed by Actavis Laboratories FL, Inc.. (Higgins, James) (Entered: 11/21/2017)

2017-11-21

1

View

APPEAL - Credit Card Payment of $505.00 received re 188 Notice of Appeal (Federal Circuit) filed by Actavis Laboratories FL, Inc.. ( Filing fee $505, receipt number 0311-2270600.) (Higgins, James)

2017-11-21

1

No Actions

- APPEAL - Credit Card Payment (Attorneys Only)

2017-11-21

1

No Actions

Notification regarding 188 Notice of Appeal (Federal Circuit) sent to Reporter Dibbs (lmm)

2017-11-22

1

No Actions

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 188 Notice of Appeal (Federal Circuit). (lmm)

2017-11-22

1

No Actions

USCA Appeal Record Sent to Reporter Dibbs

2017-11-22

1

No Actions

USCA Notice of Appeal and Docket Transmitted

2017-11-22

1

No Actions

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 188 Notice of Appeal (Federal Circuit), filed by Actavis Laboratories FL, Inc.. USCA Case Number 18-1221. (nms) (Entered: 11/27/2017)

2017-11-27

1

View

TRANSCRIPT REQUEST by Actavis Laboratories FL, Inc. Transcripts already on file. (Higgins, James) (Entered: 11/30/2017)

2017-11-30

1

View

ORDER of USCA as to 188 Notice of Appeal (Federal Circuit), filed by Actavis Laboratories FL, Inc.. Decision of USCA: The appeal is stayed (see Order for further details). (nms) (Entered: 04/23/2018)

2018-04-23

1

View

ORDER of USCA re 188 Notice of Appeal (Federal Circuit), filed by Actavis Laboratories FL, Inc.. Decision of USCA: The motion to substitute is granted. The revised official caption and short caption are reflected above. The motion to lift the stay and set a briefing schedule is granted to the extent that Nalpropion's response brief is due not later than September 28, 2018 and Actavis' reply brief is due no later than November 13, 2018. (nms) Modified on 9/20/2018 (nms). (Entered: 09/19/2018)

2018-09-19

1

View

ORDER of USCA as to 188 Notice of Appeal (Federal Circuit), filed by Actavis Laboratories FL, Inc.. Decision of USCA: Actavis's motion for leave to file an opposition is granted. Nalpropion's motion to strike is deferred to the merits panel assigned to this appeal. A copy of the motion, opposition, reply, and this order shall be transmitted to the assigned merits panel. Within seven days from the date of this order, Nalpropion may file a supplemental appendix containing the rebuttal information, which shall also be transmitted to the merits panel. (nms) (Entered: 01/18/2019)

2019-01-17

1

View

ORDER of USCA for the Federal Circuit as to 188 Notice of Appeal (Federal Circuit), filed by Actavis Laboratories FL, Inc.. Decision of USCA for the Federal Circuit: The petition for panel rehearing is denied. The petition for rehearing en banc is denied. The mandate of the court will issue on December 23, 2019. (nms) (Entered: 12/16/2019)

2019-12-16

1

View

MANDATE of USCA as to 188 Notice of Appeal (Federal Circuit), filed by Actavis Laboratories FL, Inc.. USCA Decision: Affirmed-In-Part and Reversed-In-Part. (Attachments: # 1 Opinion, # 2 Judgment)(nms) (Entered: 12/27/2019)

2019-12-23

1

View

ORAL ORDER: A joint status letter on how to proceed in light of the Mandate (D.I. 195 ) is due no later than seven (7) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/3/2020. (nms) (Entered: 01/03/2020)

2020-01-03

1

View

Oral Order

2020-01-03

1

No Actions

Unopposed MOTION to Substitute Nalpropion Pharmaceuticals, Inc. as Plaintiff for Orexigen Therapeutics, Inc. - filed by Orexigen Therapeutics, Inc.. (Kraftschik, Stephen) Modified on 1/8/2020 (nms). (Entered: 01/08/2020)

2020-01-08

1

View

ORDER Granting 197 Unopposed MOTION to Substitute Nalpropion Pharmaceuticals, Inc. as Plaintiff for Orexigen Therapeutics, Inc.. Signed by Judge Richard G. Andrews on 1/8/2020. (nms) (Entered: 01/08/2020)

2020-01-08

1

View

MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde and Christopher P. Borello - filed by Nalpropion Pharmaceuticals, Inc.. (Kraftschik, Stephen) (Entered: 01/08/2020)

2020-01-08

1

View

NOTICE requesting Clerk to remove Chad J. Peterman, Bruce M. Wexler, Simon F. Kung and Michael F. Werno and the law firm of Paul Hastings LLP as co-counsel. Reason for request: no longer associated with the action. (Kraftschik, Stephen) (Entered: 01/08/2020)

2020-01-08

1

View

SO ORDERED

2020-01-08

1

No Actions

SO ORDERED, re 199 MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde and Christopher P. Borello, filed by Nalpropion Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 1/8/2020. (nms)

2020-01-08

1

No Actions

Letter to The Honorable Richard G. Andrews from Stephen J. Kraftschik regarding Joint Status Report. (Kraftschik, Stephen) (Entered: 01/10/2020)

2020-01-10

1

View

NOTICE of Withdrawal of Counsel of Stephen J. Kraftschik, by Nalpropion Pharmaceuticals, Inc. (Kraftschik, Stephen) Modified on 2/14/2020 (nms). (Entered: 02/14/2020)

2020-02-14

1

View

ORAL ORDER: A joint status letter is due no later than three (3) days from the date of this Order. Ordered by Judge Richard G. Andrews on 10/14/2020. (nms) (Entered: 10/14/2020)

2020-10-14

1

View

Oral Order

2020-10-14

1

No Actions

Letter to The Honorable Richard G. Andrews from Rodger D. Smith II regarding Joint Status Report. (Attachments: # 1 Proposed Amended Final Judgment)(Smith, Rodger) (Entered: 10/19/2020)

2020-10-19

1

View

AMENDED FINAL JUDGMENT (CASE CLOSED). Signed by Judge Richard G. Andrews on 10/20/2020. (nms) (Entered: 10/20/2020)

2020-10-20

1

Download

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,375,111 B2; 7,462,626 B2; 8,916,195 B2; 9,125,868 B2. (Attachments: # 1 Amended Final Judgment)(nms) (Entered: 10/22/2020)

2020-10-22

1

View

Letter to Counsel, dated 10/23/2020, from the Clerk of Court, regarding the return or disposal of trial exhibits (see Exhibit List at D.I. 168 ). (nms) (Entered: 10/23/2020)

2020-10-23

1

View

ACKNOWLEDGMENT OF RECEIPT of Plaintiff's exhibits and joint exhibits for the bench trial held on June 5, 2017, through June 7, 2017 (see D.I. 168 Exhibit List). (nms) (Entered: 10/30/2020)

2020-10-30

1

View

ACKNOWLEDGMENT OF RECEIPT of Defendant's exhibits for the bench trial held on June 5, 2017, through June 7, 2017 (see D.I. 168 Exhibit List). (nms) (Entered: 11/16/2020)

2020-11-16

1

View

Overview

Parties

Defendant

Actavis Laboratories FL, Inc.

Represented By

Plaintiff